Completion of 160 tests conducted in less than 90 minutes demonstrates a level of speed and efficiency beyond the limits of traditional testing approaches NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- ...
NEW YORK, July 15, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...
Mediver Co., Ltd. (CEO Yoo Seunggu), a company specializing in medical electronic drugs, has been finally selected as a recipient for the 'Deep Tech ...
(RTTNews) - Intelligent Bio Solutions Inc. (INBS) announced Wednesday the rapid expansion of its Intelligent Fingerprinting Drug Screening System across Sweden, Norway, and Denmark through its ...
An exosome-based treatment of glioblastoma multiforme (GBM) has received orphan drug designation from the FDA. 1 Exousia AI, ...
Unlike traditional approaches that rely on medications or restrictive diets, Fuzzle provides a drug-free solution that works with ... one step closer to potentially offering people a novel, ...
Announces NDV-01 9-Month Follow-up Safety and Efficacy Data in NMIBC FDA feedback supports 2 potential registrational trials – 1) a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback